Express Scripts Holding Co.  (ESRX)
Other Ticker:  
Price: $0.0000 $0.00 %
Day's High: 0.00 Week Perf:
Day's Low: $ 0.00 30 Day Perf:
Volume (M): 0 52 Wk High: $ 0.00
Volume (M$): $ 0 52 Wk Avg: $0.00
Open: $0.00 52 Wk Low: $0.00

 Market Capitalization (Millions $) -
 Shares Outstanding (Millions) 568
 Employees 29,500
 Revenues (TTM) (Millions $) 101,353
 Net Income (TTM) (Millions $) 4,910
 Cash Flow (TTM) (Millions $) 310
 Capital Exp. (TTM) (Millions $) 331

Express Scripts Holding Co.
Express Scripts Holding Co. is a healthcare company that is engaged in providing integrated pharmacy benefit management services to clients across the United States. It is one of the largest pharmacy benefit management companies in the country and has a network of approximately 83 million members.

The company was founded in 1986 and is headquartered in St. Louis, Missouri. It was initially a subsidiary of a medical services company called Intermed, but it became a standalone company in 199 Since then, it has grown through acquisitions, partnerships, and expansion into new markets.

Express Scripts Holding Co. primarily operates through three segments: pharmacy benefit management (PBM), specialty pharmacy, and other healthcare services. The PBM segment provides a range of services, including formulary management, clinical programs, and data analytics. Its specialty pharmacy segment focuses on the delivery of drugs for chronic or complex medical conditions, such as cancer and multiple sclerosis. In addition, the company also provides various healthcare services, such as medication adherence programs and telemedicine services.

The company's clients include employers, health plans, government health programs, and individuals. It works with a wide range of healthcare providers, including retail pharmacies, mail-order pharmacies, and specialty pharmacies.

One of the key strengths of Express Scripts Holding Co. is its data analytics capabilities. The company has a vast database of healthcare information and uses advanced data analytics to provide insights and improve patient outcomes. It also leverages technology solutions to improve the pharmacy experience for its clients and their members.

Another strength of the company is its commitment to sustainability and social responsibility. It has implemented various initiatives to reduce its environmental footprint and support the communities in which it operates.

In 2018, Express Scripts Holding Co. was acquired by Cigna Corporation, a global health services company. The acquisition has merged the two companies' strengths and resources and has created a more comprehensive and integrated healthcare offering for clients and members.



Stock Performances by Major Competitors

5 Days Decrease / Increase
CAH        2.76% 
CVS   -3.12%    
RAD        4.56% 
MDRX   -15.79%    
OPRX        3.93% 
• View Complete Report

Petiq Inc

2. Battling Losses: PetIQ Inc Struggles to Achieve Profitability Despite Impressive Revenue Growth

PETQ Reports Increased Loss Per Share for Recent Fiscal Period
EAGLE, Idaho, Feb. 07, 2024 - PetIQ, Inc. (PetIQ or the Company) (Nasdaq: PETQ), a leading pet medication and wellness company, announced its financial results for the fourth quarter and full year ended December 31, 2023. Despite some unfavorable numbers, the company remains optimistic about its future performance.
For the most recent fiscal period, PETQ reported a loss per share of $-0.60, compared to $-0.24 in the previous year. The Income per Share also fell from $0.02 to -$0.60 sequentially. However, there was a notable increase in revenue, which grew by 19.937% to $220.78 million from $184.08 million in the same quarter of the previous year.

Nu Skin Enterprises Inc

Nu Skin Enterprises Inc. Reports Significant Decline in 2023 Q4 Revenue and Profits, Raising Concerns About Financial Stability

Nu Skin Enterprises Faces Significant Revenue and Profit Declines in Q4 2023
Nu Skin Enterprises Inc. (NYSE: NUS) recently released its fourth quarter and full-year 2023 financial results, which showed a significant decline in revenue and profits. In the fourth quarter of 2023, the company's revenue decreased by a staggering -6.518% to $488.30 million, compared to $498.27 million in the previous quarter. This decline in revenue directly impacted the company's profits, which plummeted by -87.26% to $0.15 per share, down from $1.16 per share in the corresponding quarter one year ago.
The decline in revenue and profits is a cause for concern for Nu Skin Enterprises shareholders. The company's bottom-line also suffered, with a -87.27% decrease in net income from $57.215 million in the corresponding period a year before to $7.282 million in the fourth quarter of 2023. This significant decline in profits raises doubts about the company's ability to maintain its financial stability and sustainability.

Mckesson Corporation

Despite Strong Revenue, McKesson Corporation's Earnings Decline in Q3 2024

McKesson Corporation, a leading healthcare services company, has experienced a significant increase in its stock performance in recent months. Over the past three months, the company's stock has improved by 15.42%. However, during the month of February, the stock dropped by 2.94%. Despite this dip, McKesson Corporation's stock has reached its 52-week high.
One of the factors contributing to the fluctuation in McKesson Corporation's stock price is its financial performance. In the third quarter of the 2024 earnings season, the company experienced a decline in earnings per share (EPS) while revenue increased. EPS plummeted by -42.3% to $4.42 per share, while revenue showed an admirable increase of 14.765% to $80.90 billion compared to the same reporting season the previous year.

Cvs Health Corporation

CVS Health Corporation Sees Decrease in Fourth Quarter 2023 Earnings Amidst Impressive Revenue Growth

CVS Health Corporation, a leading Pharmacy Services and Retail Drugstore company, experienced a slight decline in its shares during the month of February 2024. The shares dropped by -0.22%, bringing the year-to-date performance to -8.77%. Currently trading on the NYSE, CVS Health Corporation's shares are valued at 1% above its 52-week average.
During the period from October to December 2023, CVS Health Corporation witnessed a reduction in its earnings per share (EPS) despite a significant increase in revenue. The profitability decreased by -9.26% to $1.59 per share, while the revenue grew extensively by 11.887% to $93.81 billion compared to the same period the previous year. This growth in revenue outpaced the top-line performance of most other companies in the Pharmacy Services and Retail Drugstore sector, as they reported an average revenue advance of 11.61% in the fourth quarter of 2023 compared to the previous year.

Cardinal Health Inc

Cardinal Health Inc Surges Ahead with Spectacular Q2 Revenue Surge: A Promising Outlook for the Pharmacy Services and Retail Drugstore Leader

Cardinal Health Inc, a leading healthcare services company, has shown strong growth in its shares and financial results. With a notable increase in earnings per share (EPS), revenue, and net earnings, the company seems poised for continued success. This article aims to analyze the impact of these positive developments on Cardinal Health Inc's future prospects.
1. Share Performance and Momentum:
Cardinal Health Inc shares have experienced a remarkable improvement of 8.36% in the past 30 days. Over the last 12 months, the shares have advanced by an impressive 75.72%. The shares are now only 1.9% away from reaching their 52-week high of $111.4. This upward trend indicates growing investor confidence and suggests a positive market reception for the company.


Express Scripts Holding Co.'s Segments
Network revenues
 Segment     of total Revenue
Mail revenues
 Segment     of total Revenue
Other revenues
 Segment     of total Revenue
Service revenues
 Segment     of total Revenue
 Segment     of total Revenue
 Segment     of total Revenue
• View Complete Report

Express Scripts Holding Co.'s Operating Statistics Decrease / Increase
Network claims (in millions)   Network claims (in millions) Decline   
Home delivery claims (in millions)   Home delivery claims (in millions) Decline   
Total PBM claims (in millions)   Total PBM claims (in millions) Decline   
Avg. Rev. Per Network claim ($)   Avg. Rev. Per Network claim ($) Decline   
Avg. Rev. Per Home delivery claim ($)   Avg. Rev. Per Home delivery claim ($) Decline   
Total adjusted claims (in millions)   Total adjusted claims (in millions) Decline   
Avg. Income per Adjusted Claim ($)   Avg. Income per Adjusted Claim ($) Decline   


About us


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com